Covid: J&J will ask Ema for authorization for the double dose

2021-11-17T12:34:21.150Z

Studies show 100% efficacy against severe forms (ANSA) Clinical trials on the Johnson & Johnson (Janssen) vaccine have shown 100% efficacy against severe Covid-19 after two doses and 75% after a single dose. Johnson & Johnson (J&J) said this in a note. The company therefore communicated its intention to submit to the European Medicines Agency (EMA) the authorization request for a complete package that includes the single dose plus a booster dose. The